Skip to main content

Table 1 Baseline characteristics and intraoperative characteristics

From: Effect of epidural dexmedetomidine in single-dose combined with ropivacaine for cesarean section

 

Group R

(n = 46)

Group RD

(n = 46)

F/Z

p-value

   

F

 

Average age (years)

30.5 ± 3.7

29.8 ± 3.3

0.338

0.563

Weight (kg)

67.6 ± 8.4

69.2 ± 9.4

0.188

0.665

Height (cm)

159.4 ± 5.8

158.4 ± 5.0

1.659

0.201

Gestation(weeks)

38.6 ± 1.0

39.0 ± 1.1

0.003

0.956

Initial vital signs

    

 Systolic BP (mmHg)

115.7 ± 10.3

117.6 ± 10.0

0.360

0.550

 Diastolic BP (mmHg)

72.7 ± 9.4

72.6 ± 7.8

2.694

0.104

 Heart rate (beats/min)

84.5 ± 13.4

85.8 ± 13.1

0.005

0.941

Intraoperative measures

    

 Length of surgery (min)

37.5 ± 6.3

39.3 ± 6.8

0.216

0.643

 Blood loss (ml)

251.0 ± 61.5

281.5 ± 62.7

0.124

0.725

 Urine volume (ml)

81.3 ± 51.5

104.1 ± 78.5

3.115

0.081

   

Z

 

Intraoperative pain (NRS)

    

 T2

1.96 ± 1.69

0.96 ± 1.40

-3.017

0.003

 T3

1.20 ± 1.39

0.20 ± 0.62

-4.559

< 0.001

 T4

1.43 ± 1.47

0.43 ± 1.00

-3.973

< 0.001

Sufentanil consumption (µg)

0.43 ± 1.42

0.11 ± 0.737

-1.372

0.170

  1. Data are expressed as mean ± SD; statistical analysis was conducted using independent-samples t test or Mann-Whitney U test; Group R, ropivacaine group; Group RD, ropivacaine with dexmedetomidine group; BP, blood pressure; T2, fetal delivery; T3, uterus suture; T4, peritoneal closure; p < 0.05 was considered statistically significant